Enclomiphene FAQ: fertility, dosing, and legal status

Last updated 2026-07-30

What is enclomiphene and how does it raise testosterone?

Enclomiphene is the trans-isomer of clomiphene citrate. It works as a selective estrogen receptor modulator (SERM), meaning it blocks estrogen receptors in the hypothalamus. Your brain reads that as "estrogen is low," so it ramps up GnRH pulses, which push the pituitary to release more LH and FSH. More LH means more signal to the testes to make testosterone. More FSH means more signal to keep sperm production running. That mechanism is the whole story of why enclomiphene gets discussed as a TRT alternative. Testosterone injections or gels replace testosterone from the outside. That outside supply tells the hypothalamus and pituitary to shut down their own signaling (classic negative feedback), which drops LH and FSH and, over months, shrinks the testes and can suppress sperm counts. Enclomiphene instead raises your own production by working upstream. The pituitary stays active, sometimes more active than baseline. A 2021 pharmacokinetic and endocrine study on enclomiphene in men with secondary hypogonadism found it raised total testosterone into the normal range while maintaining LH, FSH, and sperm parameters, in contrast to testosterone therapy which suppressed gonadotropins ^[1]. That's the core data point behind every fertility-preservation claim you'll read about enclomiphene.

Is enclomiphene FDA-approved?

No. Enclomiphene is not FDA-approved as a standalone drug in the United States. The furthest it got was a development program called Androxal, run by Repros Therapeutics, which pursued FDA approval for secondary hypogonadism in the 2010s. That program did not reach approval. Repros discontinued the program after regulatory setbacks, and no company currently holds an approved New Drug Application (NDA) for enclomiphene citrate ^[2]. What's sold today comes from compounding pharmacies operating under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act, which allows pharmacies to prepare customized medications based on a valid prescription when a commercially available, FDA-approved equivalent doesn't exist ^[3]. That's a real, legal pathway, but it's different from buying an FDA-approved tablet off a pharmacy shelf. Compounded drugs are not FDA-evaluated for safety, efficacy, or manufacturing consistency the way approved drugs are. The FDA's own guidance is direct on this: compounded drugs "are not FDA-approved," and patients should understand that distinction before starting one ^[3]. Practically, this means dosing, purity, and quality control depend on the specific compounding pharmacy filling your prescription, not on a single standardized manufacturing process. Anyone selling enclomiphene should be transparent about which pharmacy is actually compounding and dispensing it, and a legitimate clinician-reviewed pathway should name that pharmacy rather than staying vague about sourcing.

What's the difference between enclomiphene and clomiphene?

Clomiphene citrate (brand name Clomid) is a mixture of two isomers: enclomiphene (the trans-isomer, roughly 62%) and zuclomiphene (the cis-isomer, roughly 38%) ^[4]. Enclomiphene is one half of that mixture, isolated and used on its own. The isomers behave differently in the body. Enclomiphene has a short half-life (around 10 hours) and acts as an estrogen receptor antagonist, which is the effect driving the LH/FSH increase. Zuclomiphene has a much longer half-life, reportedly persisting in circulation for weeks, and has some estrogen-agonist activity, which some researchers believe contributes to side effects like mood changes and visual disturbances seen with clomiphene ^[5]. The theoretical appeal of isolated enclomiphene is getting the testosterone-raising effect without the zuclomiphene along for the ride. Whether that translates into a meaningfully better side effect profile in practice is less settled than marketing sometimes suggests; head-to-head trial data comparing enclomiphene alone against full clomiphene in men is limited. Clomiphene itself is FDA-approved, but only for female infertility, not for male hypogonadism; its use in men is off-label ^[6].

Does enclomiphene really preserve fertility better than TRT?

The mechanistic case is strong and the early clinical data supports it, but "preserves fertility" doesn't mean "guarantees a pregnancy." Because enclomiphene keeps LH and FSH signaling active rather than shutting it down, sperm production generally continues, and testicular volume tends to stay stable rather than shrink, which is the well-documented pattern with exogenous testosterone therapy ^[1]. Standard testosterone replacement suppresses spermatogenesis in the large majority of men within months, an effect studied for decades in male contraception trials, where exogenous testosterone was used specifically because it reliably shuts down sperm production ^[7]. That's the comparison point: TRT's fertility risk isn't a rare side effect, it's close to the expected mechanism of action. For enclomiphene, published data is smaller in scale and mostly short-to-medium term (weeks to a year), coming from trials designed around testosterone and gonadotropin levels rather than pregnancy or live-birth outcomes. Nobody should read "preserves fertility" as a guarantee of conception; it means the hormonal machinery driving sperm production stays intact instead of getting turned off, based on the endocrine markers studied so far. For a deeper look at what the published trials actually measured and how strong that evidence base is, see enclomiphene reviews and enclomiphene success rate.

Who is a candidate for enclomiphene, and who isn't?

Enclomiphene is generally considered for men with secondary hypogonadism (low testosterone caused by low pituitary/hypothalamic signaling rather than primary testicular failure) who still want to preserve fertility or avoid testicular shrinkage. That includes men actively trying to conceive, men who plan to in the next few years, and men who simply don't want the size changes and shutdown that come with injectable testosterone. It's a poor fit for men with primary hypogonadism, meaning the testes themselves can't respond even when LH and FSH rise. In that situation, pushing more signal doesn't help because the receiving organ is the problem, not the signal. It's also not a fit for men who need testosterone urgently corrected regardless of fertility, since enclomiphene's testosterone increase is generally slower and more modest than injectable TRT. A baseline hormone panel (total and free testosterone, LH, FSH, estradiol, and often SHBG) plus a semen analysis if fertility is a stated goal is the reasonable starting point before treatment, and follow-up labs around 6 to 8 weeks in are standard practice for dose adjustment given typical review protocols used by telehealth and endocrinology clinics.

What's a typical enclomiphene dose, and how fast does it work?

Doses used in published research and current compounding practice commonly range from 12.5 mg to 25 mg daily, sometimes dosed a few days per week rather than every day, though protocols vary by prescriber and there's no FDA-approved label to standardize against. The 2021 pharmacokinetic study used 12.5 mg and 25 mg daily doses over 3 months and found both raised testosterone into normal range with a dose-dependent effect on magnitude ^[1]. Most men see measurable testosterone increases within 2 to 4 weeks, with levels typically stabilizing by 6 to 8 weeks after a dose is set. That's slower to "feel" than an injection, in part because the mechanism is indirect (raising LH first, which then raises testosterone), and because SERMs don't create the same day-of peak that an injection does. If you want a week-by-week sense of what to expect symptomatically, enclomiphene results timeline and enclomiphene before and after lay out reported patterns in more detail.

What are the side effects of enclomiphene?

Reported side effects in the enclomiphene literature include headache, mild mood changes, hot flashes or flushing, and in some cases elevated estradiol (since more LH also means more testosterone available for peripheral conversion to estradiol via aromatase). The 2021 study on enclomiphene reported it was generally well tolerated over the 3-month study period, with adverse events comparable across dose groups and no reported serious treatment-related events in that trial population ^[1]. Because SERMs act on estrogen receptors broadly, more than in the hypothalamus, visual disturbances have been reported with clomiphene and, less commonly, with enclomiphene; anyone noticing changes in vision should stop and contact their prescriber rather than wait it out. Mood effects (irritability, low-level anxiety) are also reported anecdotally and in some trial data, though they appear less frequent and less severe than what's described with full clomiphene, likely because zuclomiphene isn't present. Routine monitoring (testosterone, estradiol, LH, FSH, and a basic metabolic and lipid panel) is standard practice for catching problems early rather than waiting for symptoms. A full breakdown of what's actually documented in trials versus what's anecdotal is covered in enclomiphene pros and cons.

Is enclomiphene legal, and can I get it without a prescription?

In the US, enclomiphene requires a prescription. It is dispensed by licensed compounding pharmacies under a valid prescription, per FDA's compounding framework under Sections 503A and 503B of the FD&C Act ^[3]. Buying it without a prescription, commonly seen through "research chemical" or gray-market websites, means no clinician oversight, no lab monitoring, and no accountability for what's actually in the vial or capsule; the FDA has repeatedly warned about quality and identity problems with unregulated compounded and research-labeled products ^[3]. That's a real legal and safety line, not a technicality. A product with no FDA approval and no prescription oversight has no verified dose accuracy, no sterility testing standard, and no adverse event reporting structure behind it. If you're going to use enclomiphene, doing it through a telehealth prescriber that orders labs and names the compounding pharmacy filling the prescription is the difference between a monitored treatment and an unregulated gamble.

How much does enclomiphene cost compared to TRT?

Costs vary widely by pharmacy, dose, and whether it's bundled with a telehealth membership, but compounded enclomiphene commonly runs somewhere in the range of $60 to $150 per month in current direct-to-consumer telehealth pricing, before considering consultation or lab fees. Because it's compounded rather than FDA-approved and insurance-covered, most men pay out of pocket in full, unlike some generic testosterone formulations that can be covered by insurance for a documented hypogonadism diagnosis. TRT itself isn't necessarily cheaper: generic testosterone cypionate injections can be low-cost if insurance covers them, but testosterone gels and branded formulations run considerably higher, plus there's the added cost (financial and logistical) of adding hCG or a separate fertility-preservation drug if a man on TRT wants to protect sperm production, since TRT alone doesn't offer that. The full cost breakdown against alternatives, including whether the price is justified by the fertility angle for a given reader's situation, is covered in is enclomiphene worth it.

How is enclomiphene different from hCG or Clomid for fertility preservation on TRT?

These get lumped together, but they work differently. hCG mimics LH directly at the testes, keeping testicular testosterone production and sperm production going even while a man is on exogenous TRT that suppresses his own LH/FSH; it's an add-on to TRT, not a replacement for it. Clomiphene (the full isomer mixture) and enclomiphene both work upstream at the hypothalamus/pituitary to raise the body's own LH and FSH, which is why they're used as TRT alternatives rather than TRT add-ons. So the real comparison is: TRT + hCG (exogenous testosterone plus a testicular-support drug) versus enclomiphene alone (a single drug that raises testosterone by boosting your own signaling). Both approaches aim at similar goals through very different mechanisms, and the trial data behind each differs, hCG protocols come from decades of male infertility and hypogonadism literature, while enclomiphene's evidence base is smaller and more recent. A side-by-side breakdown of which approach fits which situation is in enclomiphene pros and cons.

How do I know if enclomiphene is working?

The objective answer is lab values: total and free testosterone should rise into normal reference range (commonly cited as roughly 300 to 1,000 ng/dL total testosterone, though lab-specific ranges vary), typically checked 6 to 8 weeks after starting or adjusting a dose. LH and FSH should stay at or above baseline rather than dropping, which is the marker that distinguishes enclomiphene's mechanism from TRT's suppressive one. Symptomatically, men report improvements in energy, libido, and mood over 4 to 8 weeks, though symptom tracking is subjective and slower to show up than lab changes. If fertility preservation or improvement is the actual goal, a semen analysis at baseline and again after a few months on treatment is the only way to know whether sperm parameters are actually holding steady or improving, since normal testosterone and LH/FSH numbers don't guarantee normal semen parameters on their own. Men looking for concrete before-and-after data points, more than general claims, will find more detail in enclomiphene before and after and enclomiphene results timeline.

What should I ask a prescriber before starting enclomiphene?

Ask which compounding pharmacy will actually fill the prescription, and whether that pharmacy is a 503A or 503B facility with a documented quality track record; Enclomiphene Direct, for instance, is provider-reviewed and names its fulfilling pharmacy partner rather than leaving that step opaque, and any legitimate provider should do the same. Ask what baseline labs are required before the first prescription, what follow-up labs are scheduled, and at what interval. Ask directly whether your case is secondary or primary hypogonadism, since that distinction determines whether enclomiphene has any chance of working at all. And if fertility is the actual goal (more than a side benefit), ask whether a baseline semen analysis is part of the plan, because testosterone and LH/FSH numbers alone don't confirm sperm production is intact.

Frequently asked questions

Does enclomiphene cause infertility?

No, the opposite is the point of using it. Enclomiphene raises LH and FSH rather than suppressing them, which is why sperm production and testicular size generally hold steady, unlike with injectable testosterone. That said, published data is limited to hormone and semen markers over months, not long-term pregnancy outcomes, so it's evidence of preserved reproductive signaling, not a fertility guarantee.

Is enclomiphene the same thing as Clomid?

No. Clomid (clomiphene citrate) is a mixture of two isomers, enclomiphene (about 62%) and zuclomiphene (about 38%) ^[4]. Enclomiphene is one isolated component of that mixture. Clomiphene is FDA-approved for female infertility only; enclomiphene alone is not FDA-approved for any indication and is available only through compounding pharmacies.

Can women take enclomiphene?

Enclomiphene as a standalone compounded product is generally discussed and marketed for male hypogonadism. Clomiphene citrate (the full isomer mixture, including zuclomiphene) is the FDA-approved drug for female ovulation induction. They aren't interchangeable products in current practice, and enclomiphene alone isn't the approved pathway for female infertility treatment.

How long can you safely stay on enclomiphene?

There's no FDA-set duration limit since there's no approved label. Published studies mostly cover 3 to 12 months. Clinicians typically manage it like other long-term hormone therapies, with labs every few months, reassessing periodically whether the man still needs it or whether an underlying cause of low testosterone should be addressed separately.

Does enclomiphene shrink or grow testicles?

Enclomiphene doesn't shrink the testes the way injectable TRT commonly does, because it keeps LH and FSH signaling active. Some men report stable or slightly increased testicular size while on it, consistent with continued gonadotropin stimulation, though this isn't a guaranteed cosmetic effect and hasn't been rigorously measured as a primary trial endpoint.

Can I switch from TRT to enclomiphene?

It's done, but not casually. Because TRT suppresses your own LH/FSH axis, that axis needs to "wake back up" after stopping exogenous testosterone, and enclomiphene can help drive that recovery. This transition should be managed by a prescriber with baseline and follow-up labs, since recovery timing varies by how long someone was on TRT.

Is enclomiphene banned in sports?

Clomiphene (and by extension enclomiphene, its isomer) is on the World Anti-Doping Agency Prohibited List as a hormone and metabolic modulator; competitive athletes subject to WADA or affiliated testing should assume it's banned in-competition and check current-year list specifics before use.

What happens if I stop taking enclomiphene?

Because enclomiphene works by stimulating your own hypothalamic-pituitary-testicular axis rather than replacing testosterone directly, stopping it generally means testosterone levels drift back toward whatever your body was producing before treatment, over days to a few weeks. There isn't the same withdrawal-style suppression concern seen when stopping long-term exogenous TRT.

Does insurance cover enclomiphene?

Rarely. Because it's compounded rather than FDA-approved, most insurance plans don't cover it, and men typically pay out of pocket through telehealth clinics or compounding pharmacies. Some plans may cover related lab work or the office visit, but the medication cost itself is usually a cash expense.

What labs should be checked before and during enclomiphene treatment?

Baseline labs typically include total and free testosterone, LH, FSH, estradiol, and SHBG, plus a semen analysis if fertility is a goal. Follow-up labs around 6 to 8 weeks after starting or adjusting dose check whether testosterone rose appropriately and whether LH/FSH and estradiol stayed in a reasonable range.

Why isn't enclomiphene FDA-approved if the research looks promising?

The main development program (Androxal, by Repros Therapeutics) pursued FDA approval for secondary hypogonadism but did not complete that process successfully, and no company has since brought a new application to approval ^[2]. Promising trial data doesn't automatically mean an approved drug; the FDA review process requires a completed application meeting its safety and efficacy standards.

Is compounded enclomiphene safe if it's not FDA-approved?

Compounded drugs are made under a different regulatory pathway (FD&C Act Sections 503A/503B) than approved drugs, and the FDA states plainly that compounded products "are not FDA-approved" and are not evaluated the same way ^[3]. Safety depends heavily on using a reputable, licensed compounding pharmacy and a prescriber who orders proper monitoring, not on the drug being unsafe by nature.

Sources

1. Wiehle et al., "Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial in men with idiopathic hypogonadotropic hypogonadism" and related enclomiphene PK/endocrine studies, Fertility and Sterility / J Sex Med: Enclomiphene raises testosterone while maintaining LH, FSH, and sperm parameters in men with secondary hypogonadism, in contrast to exogenous testosterone
2. U.S. Food & Drug Administration, Drugs@FDA database search for enclomiphene/Androxal: No approved New Drug Application exists for enclomiphene citrate (Androxal) in the United States
3. U.S. Food & Drug Administration, "Human Drug Compounding": Compounded drugs are not FDA-approved and are prepared under Sections 503A and 503B of the FD&C Act
4. PubChem, National Center for Biotechnology Information, "Enclomiphene" compound summary: Clomiphene citrate is a mixture of enclomiphene (trans-isomer) and zuclomiphene (cis-isomer)
5. Kim et al., review of clomiphene isomer pharmacology, Journal of Clinical Endocrinology context: Zuclomiphene has a longer half-life and estrogenic agonist activity distinct from enclomiphene's antagonist activity
6. U.S. Food & Drug Administration, Clomiphene Citrate label (Clomid): Clomiphene citrate is FDA-approved for female ovulation induction, and its use in men is off-label
7. National Institute of Child Health and Human Development / NIH-supported contraceptive trial literature on exogenous testosterone and spermatogenesis suppression: Exogenous testosterone administration suppresses spermatogenesis in the majority of men, the basis for its historical study as a male contraceptive